3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
12
Observational
2
Sponsor
Cancer Type
Other solid neoplasm
2
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Solid Tumor
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Blood Specimen Collection
131
Surveys and Questionnaires
130
Specimen Handling
57
Observation
55
Radiotherapy
44
Interviews as Topic
34
Surgical Procedures, Operative
32
Drug Therapy
31
Biopsy
28
Data Collection
26
Magnetic Resonance Spectroscopy
25
Nivolumab
20
Watchful Waiting
20
Immune Checkpoint Inhibitors
18
Immunotherapy
17
Magnetic Resonance Imaging
17
Therapeutics
17
Standard of Care
16
trastuzumab deruxtecan
14
Liquid Biopsy
13
Tomography, X-Ray Computed
13
palbociclib
13
Hematologic Tests
12
Restraint, Physical
12
Focus Groups
11
Genetic Testing
11
Bevacizumab
10
Positron Emission Tomography Computed Tomography
10
darolutamide
10
enzalutamide
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Blood Component Removal
×
1 year
×
Clear all
NCT04981119
2026-06-02
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
200 enrolled
NCT07137312
2025-12-23
Ex Vivo Expansion (ACT-X)
Mayo Clinic
Recruiting
24 enrolled